ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
0,00%
Dow Jones
38 589,16
-0,15%
DAX
18 020,49
0,00%
Brent Oil
82,115
-0,01%
Bitcoin
65 960,92
-1,02%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Biostar Pharmaceuticals Inc (CE) (BSPM)

  7. Biostar Pharmaceuticals Inc (CE) (BSPM) Actualités

BSPM

Biostar Pharmaceuticals (CE) (BSPM)

Biostar Pharmaceuticals Inc (CE)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:BSPM
DateHeureSourceTitreSymboleSociété
08/01/201916h16Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
24/08/201815h05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
23/08/201814h51GlobeNewswire Inc.Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from NasdaqUSOTC:BSPMBiostar Pharmaceuticals Inc (CE)
02/07/201823h26Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
16/05/201822h12Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
02/04/201822h02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
01/02/201822h05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
20/11/201722h11Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
21/04/201722h17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
13/04/201722h05Edgar (US Regulatory)Annual Report (10-k)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
20/01/201712h02Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
13/01/201722h20Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
30/12/201622h03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
19/10/201622h26Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
12/10/201622h46Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
18/07/201414h44Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
11/01/201322h34Edgar (US Regulatory)Current report filing (8-K)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
19/11/201213h33Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
15/11/201214h03Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
21/09/201222h31Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
23/04/201223h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
27/03/201213h34Edgar (US Regulatory)Annual Report (10-K)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
23/12/201122h55Edgar (US Regulatory)Amended Current report filing (8-K/A)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
01/06/201120h39Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
19/05/201116h08Edgar (US Regulatory)Amended Annual Report (10-K/A)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
05/04/201115h02Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
28/03/201112h50GlobeNewswire Inc.Biostar Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.comUSOTC:BSPMBiostar Pharmaceuticals Inc (CE)
29/12/201015h58Edgar (US Regulatory)Statement of Ownership (SC 13G)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
21/04/201014h45Edgar (US Regulatory)Securities Registration (section 12(b)) (8-A12B)USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
18/02/201007h30GlobeNewswire Inc.EquityNet Research Initiates Independent Research Coverage on Biostar Pharmaceuticals, Inc.USOTC:BSPMBiostar Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:BSPM

Dernières Valeurs Consultées

EU
RNO
Renault
SPI
SP500
S&P 500
NYSE
NKE
Nike
EU
ML
Michelin
FTSE
UKX
FTSE 100
EU
PX1
CAC 40
NASDAQ
AMZN
Amazon.com
EU
RI
Pernod Ricard
EU
ORA
Orange
EU
LR
Legrand
COIN
ETHUSD
Ethereum
EU
AF
Air FranceKLM
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés